In Alzheimer’s disease, BChE activity increases during advanced stages, while acetylcholinesterase (AChE) levels decline markedly, suggesting a compensatory mechanism in cholinergic signaling and cognitive function (Xing et al., 2021). This evidence concerns the gene ACHE and Alzheimer disease.